Selective ATP-competitive inhibitors of TOR suppress rapamycin-insensitive function of TORC2 in saccharomyces cerevisiae

ACS Chemical Biology

Volumn 7, Issue 6, 2012, Pages 982-987

  Liu, Qingsong ^a,b   Ren, Tao ^b   Fresques, Tara ^c   Oppliger, Wolfgang ^d   Niles, Brad J ^c   Hur, Wooyoung ^a,b   Sabatini, David M ^e,f   Hall, Michael N ^d   Powers, Ted ^c   Gray, Nathanael S ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

^e WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; QL IX 55; RAPAMYCIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BACTERIAL GROWTH; BINDING SITE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SACCHAROMYCES CEREVISIAE;

ADENOSINE TRIPHOSPHATE; ANTIFUNGAL AGENTS; CELL CYCLE PROTEINS; HUMANS; MODELS, MOLECULAR; MYCOSES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS; TRANSCRIPTION FACTORS;

EID: 84862510356     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300058v     Document Type: Article

References (23)

1. Arendrup, M. C., Fisher, B. T., and Zaoutis, T. E. (2009) Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues Clin. Microbiol. Infect. 15, 613-624
2. Maggon, K. (2011) Tyrosine Kinase Inhibitors R&D Review 49
3. Ptacek, J., Devgan, G., Michaud, G., Zhu, H., Zhu, X., Fasolo, J., Guo, H., Jona, G., Breitkreutz, A., Sopko, R., McCartney, R. R., Schmidt, M. C., Rachidi, N., Lee, S. J., Mah, A. S., Meng, L., Stark, M. J., Stern, D. F., DeVirgilio, C., Tyers, M., Andrews, B., Gerstein, M., Schweitzer, B., Predki, P. F., and Snyder, M. (2005) Global analysis of protein phosphorylation in yeast Nature 438, 679-684 (Pubitemid 41740579)
4. Ira, G., Pellicioli, A., Balijja, A., Wang, X., Fiorani, S., Carotenuto, W., Liberi, G., Bressan, D., Wan, L., Hollingsworth, N. M., Haber, J. E., and Foiani, M. (2004) DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1 Nature 431, 1011-1017 (Pubitemid 39434425)
5. Dinér, P., Veide, Vilg. J., Kjellén, J., Migdal, I., Andersson, T., Gebbia, M., Giaever, G., Nislow, C., Hohmann, S., Wysocki, R., Tamás, M. J., and Grøtli, M. (2011) Design, synthesis, and characterization of a highly effective Hog1 inhibitor: a powerful tool for analyzing MAP kinase signaling in yeast PLoS One 6, e20012
6. Sussman, A., Huss, K., Chio, L. C., Heidler, S., Shaw, M., Ma, D., Zhu, G., Campbell, R. M., Park, T. S., Kulanthaivel, P., Scott, J. E., Carpenter, J. W., Strege, M. A., Belvo, M. D., Swartling, J. R., Fischl, A., Yeh, W. K., Shih, C., and Ye, X. S. (2004) Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening Eukaryot. Cell 3, 932-943 (Pubitemid 39098869)
7. Chen, J., Young, S. M., Allen, C., Seeber, A., Péli-Gulli, M. P., Panchaud, N., Waller, A., Ursu, O., Yao, T., Golden, J. E., Strouse, J. J., Carter, M. B., Kang, H., Bologa, C. G., Foutz, T. D., Edwards, B. S., Peterson, B. R., Aubé, J., Werner-Washburne, M., Loewith, R. J., DeVirgilio, C., and Sklar, L. A. (2012) Identification of a small molecule yeast TORC1 inhibitor with a multiplex screen based on flow cytometry ACS Chem Biol. 10.1021/cb200452r
8. Gaber, R. F., Copple, D. M., Kennedy, B. K., Vidal, M., and Bard, M. (1989) The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol Mol. Cell. Biol. 9, 3447-3456 (Pubitemid 19189634)
9. Nawrocki, A., Fey, S. J., Goffeau, A., Roepstorff, P., and Larsen, P. M. (2001) The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance Proteomics 1, 1022-1032 (Pubitemid 33699618)
10. Liu, Q., Chang, J. W., Wang, J., Kang, S. A., Thoreen, C. C., Markhard, A., Hur, W., Zhang, J., Sim, T., Sabatini, D. M., and Gray, N. S. (2010) Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9- (quinolin-3-yl)benzo[ h ][1,6]naphthyridin-2(1 H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer J. Med. Chem. 53, 7146-7155
11. Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., James, D., Howard, Z., Dudley, P., Hughes, G., Smith, L., Maguire, S., Hummersone, M., Malagu, K., Menear, K., Jenkins, R., Jacobsen, M., Smith, G. C., Guichard, S., and Pass, M. (2010) AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity Cancer Res. 70, 288-298
12. García-Martínez, J. M., Moran, J., Clarke, R. G., Gray, A., Cosulich, S. C., Chresta, C. M., and Alessi, D. R. (2009) Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) Biochem. J. 421, 29-42
13. Yu, K., Toral-Barza, L., Shi, C., Zhang, W. G., Lucas, J., Shor, B., Kim, J., Verheijen, J., Curran, K., Malwitz, D. J., Cole, D. C., Ellingboe, J., Ayral-Kaloustian, S., Mansour, T. S., Gibbons, J. J., Abraham, R. T., Nowak, P., and Zask, A. (2009) Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin Cancer Res. 69, 6232-6240
14. Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., and Shokat, K. M. (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2 PLoS Biol. 7, e38
15. Heitman, J., Movva, N. R., and Hall, M. N. (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast Science 253, 905-909 (Pubitemid 21917235)
16. Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., and Hall, M. N. (1993) Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression Cell 73, 585-596 (Pubitemid 23143356)
17. Helliwell, S. B., Wagner, P., Kunz, J., Deuter-Reinhard, M., Henriquez, R., and Hall, M. N. (1994) TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast Mol. Biol. Cell 5, 105-118
18. Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., and Hall, M. N. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control Mol. Cell 10, 457-468 (Pubitemid 35284167)
19. Komeili, A., Wedaman, K. P., OShea, E. K., and Powers, T. (2000) Mechanism of metabolic control. Target of rapamycin signaling links nitrogen quality to the activity of the Rtg1 and Rtg3 transcription factors J. Cell Biol. 151, 863-878
20. Mulet, J. M., Martin, D. E., Loewith, R., and Hall, M. N. (2006) Mutual antagonism of target of rapamycin and calcineurin signaling J. Biol. Chem. 281, 33000-33007 (Pubitemid 46043258)
21. Aronova, S., Wedaman, K., Anderson, S., Yates, J, 3rd, and Powers, T. (2007) Probing the membrane environment of the TOR kinases reveals functional interactions between TORC1, actin, and membrane trafficking in Saccharomyces cerevisiae Mol. Biol. Cell 18, 2779-2794 (Pubitemid 47235287)
22. Wullschleger, S., Loewith, R., and Hall, M. N. (2006) TOR signaling in growth and metabolism Cell. 124, 471-484 (Pubitemid 43199434)
23. Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., and Gray, N. S. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1 J. Biol. Chem. 284, 8023-8032